Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Amazon
AMZN
|
+$842M |
| 2 |
NVIDIA
NVDA
|
+$559M |
| 3 |
Microsoft
MSFT
|
+$420M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
Moderna
MRNA
|
+$365M |
Top Sells
| 1 |
Baidu
BIDU
|
+$628M |
| 2 |
Tesla
TSLA
|
+$424M |
| 3 |
Palo Alto Networks
PANW
|
+$417M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$415M |
| 5 |
AT&T
T
|
+$389M |
Sector Composition
| 1 | Healthcare | 19.94% |
| 2 | Technology | 19.65% |
| 3 | Consumer Staples | 10.63% |
| 4 | Consumer Discretionary | 10.51% |
| 5 | Communication Services | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Empire State Realty Trust
ESRT
$1.32B
| $2.42M | ﹤0.01% |
201,400
-19,500
| -9% | -$234K |
|
2127
IZEA Worldwide
IZEA
$61.2M
| $2.42M | ﹤0.01% |
+236,850
| New | +$2.42M |
|
|
RPT
2128
Rithm Property Trust Inc.
RPT
$122M
| $2.42M | ﹤0.01% |
186,148
+51,965
| +39% | +$674K |
|
2129
First United
FUNC
$237M
| $2.41M | ﹤0.01% |
138,495
+30,784
| +29% | +$537K |
|
|
TMQ
2130
Trilogy Metals
TMQ
$350M
| $2.41M | ﹤0.01% |
958,900
-385,200
| -29% | -$967K |
|
|
CADE
2131
DELISTED
Cadence Bancorporation
CADE
| $2.41M | ﹤0.01% |
115,247
-3,700
| -3% | -$77.2K |
|
2132
BJ's Restaurants
BJRI
$687M
| $2.4M | ﹤0.01% |
+48,929
| New | +$2.4M |
|
2133
Ultralife
ULBI
$114M
| $2.4M | ﹤0.01% |
286,803
-95,787
| -25% | -$803K |
|
|
PINE
2134
Alpine Income Property Trust
PINE
$208M
| $2.4M | ﹤0.01% |
126,200
-7,300
| -5% | -$139K |
|
|
BHR
2135
Braemar Hotels & Resorts
BHR
$206M
| $2.4M | ﹤0.01% |
386,153
+286,953
| +289% | +$1.78M |
|
2136
CASI Pharmaceuticals
CASI
$32.4M
| $2.4M | ﹤0.01% |
154,631
+129,061
| +505% | +$2M |
|
2137
National Bankshares
NKSH
$190M
| $2.4M | ﹤0.01% |
68,470
+3,900
| +6% | +$137K |
|
|
PMT
2138
PennyMac Mortgage Investment
PMT
$1.07B
| $2.4M | ﹤0.01% |
113,764
-134,036
| -54% | -$2.82M |
|
2139
Marten Transport
MRTN
$949M
| $2.4M | ﹤0.01% |
145,250
-209,500
| -59% | -$3.45M |
|
2140
Barnwell Industries
BRN
$11.5M
| $2.39M | ﹤0.01% |
723,544
+297,900
| +70% | +$986K |
|
2141
AYTU BioPharma
AYTU
$20.9M
| $2.39M | ﹤0.01% |
23,868
+17,342
| +266% | +$1.74M |
|
|
KREF
2142
KKR Real Estate Finance Trust
KREF
$624M
| $2.39M | ﹤0.01% |
110,300
-191,700
| -63% | -$4.15M |
|
|
DRE
2143
DELISTED
Duke Realty Corp.
DRE
| $2.38M | ﹤0.01% |
50,300
-206,800
| -80% | -$9.79M |
|
2144
First Trust Global Tactical Commodity Strategy Fund
FTGC
$2.26B
| $2.38M | ﹤0.01% |
+100,600
| New | +$2.38M |
|
|
UBX
2145
DELISTED
Unity Biotechnology
UBX
| $2.38M | ﹤0.01% |
+51,260
| New | +$2.38M |
|
2146
Princeton Bancorp
BPRN
$223M
| $2.37M | ﹤0.01% |
82,723
+25,500
| +45% | +$731K |
|
2147
CSP Inc
CSPI
$111M
| $2.37M | ﹤0.01% |
448,576
-23,532
| -5% | -$124K |
|
2148
Flanigan's Enterprises
BDL
$50M
| $2.37M | ﹤0.01% |
58,700
-400
| -0.7% | -$16.1K |
|
2149
CB Financial Services
CBFV
$166M
| $2.37M | ﹤0.01% |
106,799
+13,600
| +15% | +$301K |
|
2150
ANI Pharmaceuticals
ANIP
$2.14B
| $2.36M | ﹤0.01% |
67,379
-47,823
| -42% | -$1.68M |
|